SOLAR: Phase Ib Dose Expansion of Selumetinib (MEK Inhibitor) and OLAparib (PARP Inhibitor) Combination in Solid Tumors with RAS Pathway Alterations and in PARP Inhibitor-Resistant Ovarian Cancer (LBA 9)
暂无分享,去创建一个
F. Meric-Bernstam | A. Naing | K. Kurnit | S. Piha-Paul | S. Fu | D. Karp | S. Pant | N. Kabil | J. Rodon | E. Dumbrava | Priya Bhosale | Aaron Shafer | Shannon Westin | B. Fellman | D. Hong | Timothy Yap | Anil Sood | Pamela Soliman | David M. Gershenson | Robert Coleman | Gordon Mills